Cost-effectiveness analysis of chronic hepatitis C treatment in the prison population in Spain

OBJECTIVES: To evaluate the cost-effectiveness of direct-acting antiviral (DAAs) treatment versus non-treatment in prisoners awaiting treatment for chronic hepatitis C (CHC) and to analyse the clinical and economic impact of the treatment on liver complications and mortality. MATERIAL AND METHOD: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Marco, A, Domínguez-Hernández, R, Casado, MA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Sanidad Penitenciaria 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537362/
https://www.ncbi.nlm.nih.gov/pubmed/32697276
http://dx.doi.org/10.18176/resp.00012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537362/
https://www.ncbi.nlm.nih.gov/pubmed/32697276
http://dx.doi.org/10.18176/resp.00012

Ejemplares similares